Overview

Long-term Clinical Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU Subjects

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
Evaluate efficacy and safety of dexmedetomidine long term administration in ICU patients who require more than 24 hours sedation.
Phase:
Phase 3
Details
Lead Sponsor:
Hospira, Inc.
Hospira, now a wholly owned subsidiary of Pfizer
Collaborator:
Maruishi Pharmaceutical
Treatments:
Dexmedetomidine